I never said China is a beggar nation wrt pharma. In fact, It has done a great job feed and cloth its people of 1.2 billion. In the past the community health based healthcare works just fine, with generic drugs and good common sense medicine. Now, everyone is seeking the magic drug to cure all, which is nonexistence. WX has the hype factor built-in, and it needs to be taken out before moving up.
Like most of the IPOs, the odd is against it moving up much, especially under this stormy market. I would bet it will go down to at least 20 before stablize (if ever).
<Like most of the IPOs, the odd is against it moving up much>
Unlike most of the IPOs, WX's IPO was much under-priced in the first place; most of the bio- or pharma- related companies debuted with nothing substantial but some nice stories and promises, but WX has been growing in leap and making good money along the way as well. It has the finest people in management, scientific team, business development, and it has the finest infrastructure and facility for drug development. Its IPO was depressingly underpriced and the in-the-known investing community has noticed it.
<I would bet it will go down to at least 20 before stablize (if ever).>
I bet you missed the boat and thus try to defer other people from snapping the shares before you load up under $30s
In a slowing economy, growth stocks like WX are more hard to find, plus, the bio and pharm business are shielded from almost any economic down turn. Come up with some facts based arguments or go away, otherwise a mere statement like "WX has the hype factor built in" (what hype?) itsself is a only viewed as a bear hype.